Colorectal Cancer Soup to Nuts
-
Register
- User - $30
An overview of the epidemiology, diagnosis, and treatment of colorectal cancer
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.0 Contact Hours; 0.50 are Pharmacology
This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 3/12/2025 to 3/11/2026 . PAs should only claim credit commensurate with the extent of their participation.
Expiration Date: March 11, 2026
$30.00
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
•As a result of this activity, the learner will understand:
•Risk factors for CRC and recent trends in incidence and mortality
•Screening strategies for CRC in average risk people
•Diagnosis and staging of CRC
•Basic principles of treatment for CRC
Raymond Couric Wadlow
M.D.
Raymond Wadlow, MD, is a gastrointestinal oncologist specializing in pancreatic and gastrointestinal cancers at Inova Schar Cancer in Farifax, VA. Dr. Wadlow graduated from the University of Virginia School of Medicine in 2000, completed internal medicine residency at the University of Pennsylvania in 2003, and did his hematology-oncology fellowship training at the Dana-Farber Cancer Institute and Massachusetts General Hospital in Boston. After seven years as a laboratory-based physician-scientist and gastrointestinal oncologist in Boston, Dr. Wadlow worked for nine years in community practice as part of the U.S. Oncology Network. In his current position, he serves as co-director of the gastrointestinal oncology research program and program director for the Inova Schar Hematology-Oncology Fellowship. Dr. Wadlow is also the director of the high-risk pancreatic clinic at the Inova Saville Cancer Screening and Prevention Center, and a principal investigator and chair of the Pancreatic Cancer Early Detection (PRECEDE) Consortium’s cancer outcomes committee.
CE/CME INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.0 contact hours, of which 0.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 3/12/2025 to 3/11/2026 .
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 3/12/2025 to 3/11/2026 . PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURES
Faculty
Contributing faculty, Raymond Couric Wadlow, M.D. has disclosed:
Johnson & Johnson Independent contractor (spouse) Lung Cancer
Pfizer Advisor Colorectal Cancer Braftovi
Exact Sciences Advisor Colorectal Cancer Cologuard
Amgen
Taiho Advisor
Advisor Colorectal Cancer Vectibix
Lonsurf
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
